Pinealon (EDR)
Synthetic Tripeptide | Neuroprotection & Cognitive Enhancement
Community Research
Join others researching Pinealon — share findings, ask questions, and learn from real experiences
Developed in Russia, Pinealon demonstrates unique DNA-interaction for neuroprotection and cognitive enhancement. Benefits traumatic brain injury recovery and age-related cognitive decline with excellent safety profile.
Penetrates nuclear membranes to directly interact with DNA, modulates gene expression via histone H1.3 binding and MAPK/ERK pathway activation.
Molecular Data
ED?Glutamic Acid
Position 1
Aspartic Acid
Position 2
Arg (EDR)
Position 3
Research Indications
Clinical protocol of 5mg daily showed significant cognitive improvements in 72-patient study.
Subcutaneous administration allows systemic circulation to brain tissue for neuroprotective effects.
Caspase-3 suppression, ROS reduction, and excitotoxicity protection.
Enhanced neurotransmitter function with 1.9x serotonin increase in cell cultures.
100 ng/kg optimal dose improved spatial learning in hippocampus.
Irisin expression increases linked to telomere protection and mitochondrial enhancement.
32-patient study showed significant improvements in aging indicators over 20-30 days.
Dosing Protocols
Highest bioavailability, direct systemic delivery, established clinical protocols.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Neuroprotection | 5mg daily | Once daily | SubQ |
| Cognitive Enhancement | 100-300mcg | Daily or every other day | SubQ |
| Anti-aging | 5mg | 20 days, 2-3x yearly | SubQ |
Reconstitution Instructions
- Lyophilized Pinealon powder
- Bacteriostatic water for injection
- Insulin syringes (30-31 gauge)
- Alcohol swabs
- 1 Remove powder and water from refrigeration
- 2 Clean vial tops with alcohol swabs; allow to dry
- 3 Draw bacteriostatic water into syringe
- 4 Inject water slowly down vial side to avoid foam
- 5 Gently swirl until completely dissolved
- 6 Store at 2-8°C
- 7 Use within 30 days
Interactions
What to Expect
Side Effects & Safety
Common Side Effects
- Minimal injection site reactions
- Mild gastrointestinal adjustment
- Occasional headache
- Fatigue
Stop Signs - Discontinue if:
- Severe headaches or mood changes
- Persistent injection site reactions
- Signs of infection at injection site
- Unusual neurological symptoms
- Allergic reactions
Contraindications
- Pregnancy
- Lactation
Quality Checklist
Good Signs
- White crystalline powder; proper freeze-drying indicated
- Clear reconstituted solution; no particles or cloudiness
- Pharmaceutical packaging with batch numbers from reputable sources
Warning Signs
- Ensure distinction between research (lab only) and pharmaceutical (human use) grade
Bad Signs
- Discolored powder (yellow or brown) indicates degradation from heat or moisture
- Cloudy solution indicates contamination
Frequently Asked Questions
Does Pinealon really interact directly with DNA, or is that marketing?
It's verified science, not marketing. Pinealon penetrates nuclear membranes and directly binds to histone H1.3 and DNA structures to modulate gene expression. Multiple peer-reviewed studies document this mechanism. It's one of the few peptides that works through direct DNA interaction rather than receptor binding.
Can I take Pinealon orally, or does it need injection?
Both work. Oral forms (0.2mg twice daily) use the 3-amino acid structure that survives stomach acid. Injection (5mg daily SubQ) offers higher bioavailability. Oral is more convenient, but injection provides direct systemic delivery. Choose based on convenience vs. guaranteed absorption preference.
Why is 40+ years of Russian clinical use relevant if it's not FDA-approved?
Russian clinical use demonstrates long-term safety data in thousands of patients—much more than most research peptides have. While it doesn't equal FDA approval, 40 years of safety documentation in clinical settings is meaningful evidence of tolerability. However, rigorous Western clinical trials remain absent.
How does Pinealon compare to P21 for brain protection?
Both target neuroprotection but work differently. Pinealon modulates MAPK/ERK pathways and increases serotonin (more mood support), while P21 increases BDNF and promotes neurogenesis (more cognitive/learning focus). Pinealon has clinical evidence; P21 is preclinical. Pinealon is better-established for TBI recovery.
References
- Human Clinical Trial - Post-Traumatic Cerebrasthenia(2015)
72 patients aged 30-74; 0.2mg twice daily; 20-30 days. Improved memory, reduced headache severity, and enhanced emotional stability compared to controls.
- Aging Study - Polymorbidity Patients(2015)
32 patients aged 41-83; variable dosing; 30 days. Significant improvements in biological aging biomarkers with anabolic effects.
- Diabetic Rat Model - Spatial Learning(2020)
100 ng/kg optimal dose; 14 days. Enhanced NMDA receptor expression in hippocampus with neuroplasticity improvements.
- 5xFAD Alzheimer's Mouse Model(2021)
400 μg/kg IP daily; 28 days. Prevention of dendritic spine loss through MAPK/ERK pathway modulation.
Related Peptides
Disclaimer
This information is for educational and research purposes only. Consult a healthcare professional before use.